Shares of Bayer BAYRY gained 12.1% after the Solicitor General supported a Supreme Court review of its Roundup weedkiller case in the United States. Bayer believes that the backing of the government ...

We came across a bullish thesis on Joint Stock Company Kaspi.kz on Margin of Sanity’s Substack. In this article, we will summarize the bulls’ thesis on KSPI. Joint Stock Company Kaspi.kz's share was ...

The Justice Department has officially dropped all criminal charges against two co-defendants of former President Trump in the Florida classified documents case, eliminating any legal jeopardy they ...

Through early Friday, bitcoin’s BTCUSD price was down 14% for 2025, after it had been up as much as 35% for the year on Oct. 6, according to CoinDesk. Joseph Adinolfi explained the financial factors ...

Shares of Bayer BAYN4.37%increase; green up pointing triangle rose as much as 14% on Tuesday after the U.S. Solicitor General supported the company’s push for the Supreme Court to take up its Roundup ...

Dycom Industries remains a buy, driven by accelerating organic growth, margin expansion, and robust demand visibility. Q3 results exceeded guidance: contract revenues up 14.1% y/y, adj. EBITDA up ~29% ...

The Bitcoin miner published its fiscal 2025 results. It more than doubled its revenue, and flipped to a net profit. In a case of exquisite timing, the company released a highly encouraging financial ...

Deaths from whooping cough have been recorded in Louisiana and Washington. More than 25,000 cases of whooping cough have been recorded in the U.S. so far this year, updated federal data shows. This ...

Fair to say the prosecution of ex-FBI Director James Comey is not going smoothly for the Department of Justice. Former FBI Director James Comey on ABC’s 20/20. U.S. Magistrate Judge William ...

It is a time of superlatives in the tech industry, with historic profits, stock prices and deal prices. It’s enough to make some people very nervous. It is a time of superlatives in the tech industry, ...

Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and ...